Develop a presentation about a medication | PHARMACOLOGY FOR PROFESSIONAL NURSING | Rasmussen College System
Slide 1: Introduction
Welcome everyone to the in-service training session! The purpose of this training is to help you, as emergency center nurses at Rasmussen General Hospital, understand how and when to properly educate clients diagnosed with low-risk deep vein thrombosis about their new medication regimen which includes oral anticoagulation therapy with rivaroxaban. To ensure that all members of the audience have a basic understanding of DVT and the use of rivaroxaban to treat it, we will first give an overview of pharmacotherapeutics, side effects/adverse reactions/interactions associated with this drug, and follow-up care. Let’s get started!
Slide 2: Pharmacotherapeutics
The drug we are discussing today is rivaraxoban (Xarelto). It is a factor Xa inhibitor used for prophylaxis against DVTs following hip or knee replacements (WebMD Contributors 2017). Riv, and goal directed. Her eye contact is somewhat avoidant during the clinical interview. When you make eye contact with her, she looks away or looks down. She demonstrates no noteworthy mannerisms, gestures, or tics. Her self-reported mood is “sad.” Affect is appropriate to content of conversation and self-reported mood. She denies visual or auditory hallucinations, and no delusional or paranoid thought processes are readily appreciated. Insight and judgment are grossly intact; however, impulse control is impaired. She is currently denying suicidal or homicidal ideation.
Diagnosis: Gambling disorder, alcohol use disorder
Decision Point One
Select what you should do:
A) Vivitrol (naltrexone) injection, 380 mg intramuscularly in the gluteal region every 4 weeks
B) Antabuse (disulfiram) 250 mg orally daily
C) Campral (acamprosate) 666 mg orally three times/day
D) Cognitive Behavioral Therapy, 1-2 sessions/week